{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:38:35Z","timestamp":1781649515525,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd004679.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000}}],"reference-count":136,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004679.pub3","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T09:11:28Z","timestamp":1491642688000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients"],"prefix":"10.1002","volume":"2017","author":[{"given":"Denise","family":"Campbell","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Mudge","sequence":"additional","affiliation":[{"name":"University of Queensland at Princess Alexandra Hospital; Department of Nephrology; Level 2, ARTS Building Ipswich Rd Woolloongabba Queensland Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; 199 Ipswich Rd Woolloongabba Queensland Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"},{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"},{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"Diaverum Academy; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archinte.1973.03650090050009","article-title":"Prophylaxis with cephalothin in peritoneal dialysis","volume":"132","author":"Axelrod","year":"1973","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0002|cit2","first-page":"147","article-title":"Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD","volume":"4","author":"Bennet-Jones","year":"1988","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0272-6386(96)90105-5","article-title":"A randomized trial of staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin","volume":"27","author":"Bernardini","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2004090773","article-title":"Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients","volume":"16","author":"Bernardini","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0005|cit5","first-page":"297","article-title":"Treatment of staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients","volume":"10","author":"Blowey","year":"1994","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0006|cit6","first-page":"A3","article-title":"Exit site care, an open labelled randomized prospective study comparing the use of povidone-iodine and chlorhexidine soap [abstract no: 6]","volume":"1","author":"Cheng","year":"1999","journal-title":"Hong Kong Journal of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/089686080802800514","article-title":"A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections","volume":"28","author":"Chu","year":"2008","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0008|cit8","first-page":"244","article-title":"Peritonitis in CAPD patients - a randomized clinical trial (RCT) of trimethoprim-sulfamethoxazole (TMP\/SMX) prophylaxis [abstract]","volume":"33","author":"Churchill","year":"1988","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/089686088800800203","article-title":"Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients: a randomized clinical trial of cotrimoxazole prophylaxis","volume":"8","author":"Churchill","year":"1988","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0010|cit10","first-page":"4","article-title":"Peritoneal dialysis catheter exit site care for the maintenance continuous ambulatory peritoneal dialysis (CAPD) patient: report of a randomised prospective study","volume":"13","author":"Cocksedge","year":"1993","journal-title":"Renal Educator"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/089686080302300614","article-title":"Comparative study of mupirocin and sodium fucidate in the prophylaxis of exit-site infections in CAPD patients","volume":"23","author":"Danguilan","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0012|cit12","first-page":"81","article-title":"A prospective randomized study of peritoneal catheter exit-site care","volume":"19","author":"Fuchs","year":"1990","journal-title":"Dialysis & Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/ajkd.2000.19104","article-title":"Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters","volume":"36","author":"Gadallah","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0014|cit14","first-page":"199","article-title":"Preoperative vancomycin prophylaxis for newly placed peritoneal dialysis catheters prevents postoperative peritonitis","volume":"16","author":"Gadallah","year":"2000","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1473-3099(13)70258-5","article-title":"Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial","volume":"14","author":"Johnson","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/089686080902900315","article-title":"The Honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients","volume":"29","author":"Johnson","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3747\/pdi.2012.00310","article-title":"The HONEYPOT randomized controlled trial statistical analysis plan","volume":"33","author":"Pascoe","year":"2013","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004679.pub3-BIB0018|cit18","first-page":"30","article-title":"Microbiological results of the Honeypot study-secondary analysis of a randomised, controlled trial of exit site application of MEDIHONEY for the prevention of catheter-associated infections in PD patients [abstract]","volume":"19","author":"Zhang","year":"2014","journal-title":"Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD004679.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3747\/pdi.2014.00206","article-title":"The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the Honeypot Trial","volume":"35","author":"Zhang","year":"2015","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(96)90466-7","article-title":"A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis","volume":"28","author":"Lo","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0021|cit21","first-page":"392","article-title":"Randomized clinical trial of cephalexin in preventing peritonitis in patients on continuous ambulatory peritoneal dialysis [abstract]","volume":"19","author":"Low","year":"1981","journal-title":"Kidney International"},{"issue":"8197","key":"10.1002\/14651858.CD004679.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(80)91981-9","article-title":"Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis","volume":"2","author":"Low","year":"1980","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0023|cit23","first-page":"25","article-title":"Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial","volume":"10","author":"Luzar","year":"1990","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00365599.1992.11690450","article-title":"Prophylactic antibiotics in the insertion of Tenckhoff catheters","volume":"26","author":"Lye","year":"1992","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0025|cit25","unstructured":"Lye WC van der Straaten JC Lee EJ A prospective study on the use of prophylactic antibiotics for the implantation of tenckhoff catheters in CAPD patients [abstract] 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel 1993 343"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0026|cit26","first-page":"139","article-title":"Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program","volume":"154","author":"Mendoza-Guevara","year":"2007","journal-title":"Contributions to Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0027|cit27","first-page":"105","article-title":"A clinical study comparing a polyurethane dressing, blisterfilm, to standard gauze dressing on the tenckhoff catheter [abstract]","volume":"16","author":"Moore","year":"1989","journal-title":"ANNA Journal"},{"issue":"7","key":"10.1002\/14651858.CD004679.pub3-BIB0028|cit28","first-page":"475","article-title":"Comparison of Blisterfilm and gauze for peritoneal catheter exit site care","volume":"16","author":"Moore","year":"1989","journal-title":"ANNA Journal"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/089686080802800112","article-title":"A randomized controlled trial comparing mupirocin versus polysporin triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study)","volume":"28","author":"Jassal","year":"2008","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2215\/CJN.07970811","article-title":"A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study","volume":"7","author":"McQuillan","year":"2012","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"8","key":"10.1002\/14651858.CD004679.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.00980112","article-title":"The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients","volume":"7","author":"Diepen","year":"2012","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"11","key":"10.1002\/14651858.CD004679.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1681\/ASN.V7112403","article-title":"Nasal mupirocin prevents staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group","volume":"7","author":"Anonymous","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0033|cit33","first-page":"439","article-title":"The effect of intranasal mupirocin on CAPD exit site infection (ESI) [abstract]","volume":"5","author":"Coles","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jac\/43.1.105","article-title":"Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized placebo-controlled trial","volume":"43","author":"Davey","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/089686088500500104","article-title":"A randomized multicenter clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis","volume":"5","author":"Nolph","year":"1985","journal-title":"Peritoneal Dialysis Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3747\/pdi.2012.00109","article-title":"Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial","volume":"34","author":"Nunez-Moral","year":"2014","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0037|cit37","first-page":"242","article-title":"Treatment of staphylococcus aureus nasal carriers in CAPD with mupirocin","volume":"8","author":"Perez-Fontan","year":"1992","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0038|cit38","first-page":"198","article-title":"Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial","volume":"35","author":"Poole-Warren","year":"1991","journal-title":"Clinical Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3747\/pdi.2008.00189","article-title":"Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.[Erratum appears in Perit Dial Int. 2011 Mar-Apr;31(2):120]","volume":"30","author":"Restrepo","year":"2010","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0040|cit40","unstructured":"Ryckelynck JP Verger C Cam G Faller B Pierre D A prospective study to evaluate the role of antiseptics in CAPD Y-line systems [abstract] 24th Annual Congress. EDTA-ERA; 1987 Oct 25-29; West Berlin, Germany 1987 161"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0041|cit41","first-page":"370","article-title":"Effect of sodium fusidate and ofloxacin on staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis","volume":"41","author":"Sesso","year":"1994","journal-title":"Clinical Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004679.pub3-BIB0042|cit42","first-page":"417","article-title":"Effect of sodium fusidate and ofloxacin on staphylococcus aureus carriage and infection in patients on peritoneal dialysis (CAPD) [abstract]","volume":"4","author":"Sesso","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000441-197109000-00005","article-title":"Trial of oral neomycin during peritoneal dialysis","volume":"262","author":"Sharma","year":"1971","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0045|cit44","first-page":"182A","article-title":"The efficiency of a silver ring to prevent exit-site and other catheter-related infections in PD-patients-final results of the SIPROCE study [abstract]","volume":"8","author":"Pommer","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0044|cit45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0272-6386(98)70130-1","article-title":"Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study","volume":"32","author":"Pommer","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0046|cit46","first-page":"227","article-title":"Efficiency of a silver ring in preventing exit-site infections in adult PD patients: results of the SIPROCE Study. Silver ring Prophylaxis of the Catheter Exit Site","volume":"13","author":"SIPROCE Study","year":"1997","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02849908","article-title":"Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients","volume":"24","author":"Sit","year":"2007","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1681\/ASN.V261085","article-title":"Preventing Staphylococcus aureus infection during chronic peritoneal dialysis","volume":"2","author":"Swartz","year":"1991","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004679.pub3-BIB0049|cit49","first-page":"S64","article-title":"A randomized trial of amuchina 10% versus povidone-iodine 10% solution for exit-site care\/infection in peritoneal dialysis patients [abstract]","volume":"15","author":"Wadhwa","year":"1995","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004679.pub3-BIB0050|cit50","first-page":"S46","article-title":"Amuchina 5% versus povidone-iodine 10% solution for exit-site care\/infection in peritoneal dialysis patients [abstract]","volume":"17","author":"Wadhwa","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0272-6386(97)91130-6","article-title":"The efficacy of exit site povidone-iodine ointment in the prevention of early peritoneal dialysis-related infections","volume":"29","author":"Waite","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ndt\/12.1.157","article-title":"One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion","volume":"12","author":"Wikdahl","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0195-6701(97)90222-X","article-title":"The use of povidone iodine in exit site care for patients undergoing continuous peritoneal dialysis (CAPD)","volume":"35","author":"Wilson","year":"1997","journal-title":"Journal of Hospital Infection"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1177\/089686080302302s32","article-title":"Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site","volume":"23 Suppl 2","author":"Wong","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0272-6386(12)80883-3","article-title":"Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections","volume":"18","author":"Zimmerman","year":"1991","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0056|cit56","first-page":"335","article-title":"Randomized, controlled trial of prophylactic rifampin (RIF) for PD catheter-related infections (CRI) and peritonitis (P) [abstract]","volume":"37","author":"Zimmerman","year":"1990","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08860220801964228","article-title":"Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience","volume":"30","author":"Cavdar","year":"2008","journal-title":"Renal Failure"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0058|cit58","first-page":"62","article-title":"The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience","volume":"20","author":"Cavdar","year":"2004","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0059|cit59","first-page":"268","article-title":"Randomized clinical trial (RCT) comparing peritonitis rates among new CAPD patients using the Y set disinfectant system (Y) to standard systems (S) [abstract]","volume":"35","author":"Churchill","year":"1989","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/089686088900900304","article-title":"Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems","volume":"9","author":"Churchill","year":"1989","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/089686080302300410","article-title":"The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections","volume":"23","author":"Crabtree","year":"2003","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0062|cit62","first-page":"18","article-title":"Pharmacokinetics of ciprofloxacin after intraperitoneal administration in uninfected patients undergoing CCPD","volume":"8","author":"Fijter","year":"1992","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0063|cit63","first-page":"233","article-title":"Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients","volume":"16","author":"Gadallah","year":"2000","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"8351","key":"10.1002\/14651858.CD004679.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(83)92528-X","article-title":"Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis","volume":"2","author":"Maiorca","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0065|cit65","first-page":"223","article-title":"'Y' connector system for prevention of peritonitis in CAPD: a controlled study","volume":"20","author":"Maiorca","year":"1983","journal-title":"Proceedings of the European Dialysis & Transplant Association"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2702.1997.tb00279.x","article-title":"A study of the efficacy of dressings in preventing infections of continuous ambulatory peritoneal dialysis catheter exit sites","volume":"6","author":"Naylor","year":"1997","journal-title":"Journal of Clinical Nursing"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0067|cit67","first-page":"149","article-title":"Efficacy of Mupirocin prophylaxis in reducing the incidence of peritoneal dialysis (PD)-related Staphylococcus aureus infections in children on chronic PD: results of a double blind, placebo-controlled trial [abstract]","volume":"22","author":"Klaus","year":"2002","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0068|cit68","first-page":"324","article-title":"Nasal carriage of staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS)","volume":"16","author":"Oh","year":"2000","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004679.pub3-BIB0069|cit69","first-page":"260A","article-title":"Oral versus intraperitoneal application of clindamycin in tunnel infections: a prospective, randomized study in CAPD patients [abstract]","volume":"8","author":"Artic","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/089686089701700512","article-title":"Oral versus intraperitoneal application of clindamycin in tunnel infections: a prospective, randomized study in CAPD patients","volume":"17","author":"Plum","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0071|cit71","first-page":"154","article-title":"Prospective randomized trial with the use of antibiotic bonding to peritoneal catheters. A method to reduce tunnel and exit site infection in CAPD patients [abstract]","volume":"36","author":"Rodriguez-Perez","year":"1989","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0072|cit72","first-page":"182","article-title":"Transperitoneal resorption of ampicillin, cefuroxim and gentamicin in continuous ambulatory peritoneal dialysis","volume":"33","author":"Thomae","year":"1982","journal-title":"Medizinische Welt"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/089686089001000115","article-title":"Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters","volume":"10","author":"Trooskin","year":"1990","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0074|cit74","unstructured":"Ruengorn C Efficacy and safety of local application of chlorhexidine gluconate versus mupirocin ointment in the prevention of peritoneal dialysis-related infection: a pilot study, double- blind, stratified randomized controlled trial www.clinicaltrials.gov\/ct2\/show\/NCT02547103"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/089686080102100604","article-title":"Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection","volume":"21","author":"Annigeri","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"9","key":"10.1002\/14651858.CD004679.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/ndt\/gfu313","article-title":"Prevention of peritoneal dialysis-related infections","volume":"30","author":"Campbell","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/089686088900900304","article-title":"Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group","volume":"9","author":"Anonymous","year":"1989","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","article-title":"Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes","volume":"64","author":"Cho","year":"2014","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2003.08.046","article-title":"Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization","volume":"43","author":"Choi","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/089686080502500413","article-title":"A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis","volume":"25","author":"Chow","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1681\/ASN.V86965","article-title":"Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group","volume":"8","author":"Churchill","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0082|cit82","unstructured":"Collier M Evans D Farrington M Gibbs E Gould K Jenkinson H Surgical site infection: prevention and treatment. Clinical guideline [CG74], 2008 www.nice.org.uk\/guidance\/cg74 1 31"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ndt\/16.2.341","article-title":"Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials","volume":"16","author":"Daly","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0084|cit84","first-page":"195","article-title":"Silver peritoneal catheters reduce bacterial colonization","volume":"10","author":"Dasgupta","year":"1994","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/089686088900900112","article-title":"Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD)","volume":"9","author":"Davies","year":"1989","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/089686089001000112","article-title":"Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients","volume":"10","author":"Digenis","year":"1990","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ki.1994.410","article-title":"Race and the risk of peritonitis: an analysis of factors associated with the initial episode","volume":"46","author":"Farias","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Figueiredo A Goh BL Jenkins S Johnson DW Mactier R Ramalakshmi S Clinical practice guidelines for peritoneal access Peritoneal Dialysis International. 2010 424 9 20628103","DOI":"10.3747\/pdi.2010.00087"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/089686089401400305","article-title":"Higher incidence of peritonitis in native Canadians on continuous ambulatory peritoneal dialysis","volume":"14","author":"Fine","year":"1994","journal-title":"Peritoneal Dialysis International"},{"issue":"10","key":"10.1002\/14651858.CD004679.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1681\/ASN.V7102176","article-title":"Peritonitis influences mortality in peritoneal dialysis patients","volume":"7","author":"Fried","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/089686089601600414","article-title":"Biocompatibility of silver-coated peritoneal dialysis catheter in a porcine model","volume":"16","author":"Fung","year":"1996","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3747\/pdi.2010.00131","article-title":"Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients","volume":"31","author":"Ghali","year":"2011","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0272-6386(96)90502-8","article-title":"Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies","volume":"28","author":"Golper","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"7650","key":"10.1002\/14651858.CD004679.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jama.291.6.740","article-title":"Underutilization of peritoneal dialysis","volume":"291","author":"Heaf","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2307\/30140952","article-title":"Recommendations for preventing the spread of vancomycin resistance.[Erratum appears in Infect Control Hosp Epidemiol 1995 Sep;16(9):498]","volume":"16","author":"Hospital Infection Control Practices Advisory Committee (HICPAC)","year":"1995","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD004679.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0098|cit98","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/089686089301300109","article-title":"A comparison of peritoneal dialysis-related infections in black and white patients","volume":"13","author":"Holley","year":"1993","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-10-3","article-title":"Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study","volume":"10","author":"Jaar","year":"2009","journal-title":"BMC Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004679.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2011060607","article-title":"Global trends in rates of peritoneal dialysis","volume":"23","author":"Jain","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1473-3099(13)70258-5","article-title":"Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial","volume":"14","author":"Johnson","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/089686080002000406","article-title":"Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update.[Erratum appears in Perit Dial Int 2000 Nov-Dec;20(6):828-9]","volume":"20","author":"Keane","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1797.2005.00374.x","article-title":"Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA","volume":"10","author":"Lim","year":"2005","journal-title":"Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD004679.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/ndt\/gft002","article-title":"The risk of peritonitis after an exit site infection: a time-matched, case-control study","volume":"28","author":"Lloyd","year":"2013","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/089686080402400408","article-title":"Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations","volume":"24","author":"McDonald","year":"2004","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0107|cit107","doi-asserted-by":"crossref","unstructured":"Moher D Pham B Jones A Cook DJ Jadad AR Moher M Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998 609 13 9746022","DOI":"10.1016\/S0140-6736(98)01085-X"},{"issue":"12","key":"10.1002\/14651858.CD004679.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1093\/ndt\/gfr177","article-title":"Characteristics of dialysis important to patients and family caregivers: a mixed methods approach","volume":"26","author":"Morton","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD004679.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2215\/CJN.00910209","article-title":"Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database","volume":"4","author":"Nessim","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00002480-198704000-00003","article-title":"Factors associated with morbidity and mortality among patients on CAPD","volume":"33","author":"Nolph","year":"1987","journal-title":"ASAIO Transactions"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/089686089401400208","article-title":"Risk factors for peritoneal dialysis-related infections","volume":"14","author":"Oxton","year":"1994","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0272-6386(12)80434-3","article-title":"Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results","volume":"22","author":"Perez-Fontan","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(89)80018-6","article-title":"Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis","volume":"13","author":"Piraino","year":"1989","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0272-6386(12)80560-9","article-title":"A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients","volume":"16","author":"Piraino","year":"1990","journal-title":"American Journal of Kidney Diseases"},{"issue":"10","key":"10.1002\/14651858.CD004679.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1681\/ASN.V9101956","article-title":"Peritonitis as a complication of peritoneal dialysis","volume":"9","author":"Piraino","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002480-200011000-00031","article-title":"Staphylococcus aureus infections in dialysis patients: focus on prevention","volume":"46","author":"Piraino","year":"2000","journal-title":"ASAIO Journal"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/089686080202200504","article-title":"ADEMEX: how should it change our practice? Adequacy of peritoneal dialysis in Mexico","volume":"22","author":"Piraino","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD004679.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3747\/pdi.2011.00057","article-title":"ISPD position statement on reducing the risks of peritoneal dialysis-related infections","volume":"31","author":"Piraino","year":"2011","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/089686089701703S09","article-title":"Selection of peritoneal dialysis for pediatric patients","volume":"17 Suppl 3","author":"Salusky","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128072-200305050-00004","article-title":"Management of peritonitis in children receiving chronic peritoneal dialysis","volume":"5","author":"Schaefer","year":"2003","journal-title":"Paediatric Drugs"},{"issue":"5","key":"10.1002\/14651858.CD004679.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0122|cit122","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0123|cit123","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.27.4.495","article-title":"Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use","volume":"27","author":"Sutherland","year":"1985","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0125|cit125","first-page":"257","article-title":"The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis","volume":"16","author":"Thodis","year":"2000","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0272-6386(98)70026-5","article-title":"Differing outcomes of gram-positive and gram-negative peritonitis","volume":"32","author":"Troidle","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0272-6386(03)00661-9","article-title":"Depression and its association with peritonitis in long-term peritoneal dialysis patients","volume":"42","author":"Troidle","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004679.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1473-3099(13)70284-6","article-title":"Medihoney: let nature do the work?","volume":"14","author":"Biesen","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD004679.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.00980112","article-title":"The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients","volume":"7","author":"Diepen","year":"2012","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0130|cit130","doi-asserted-by":"crossref","unstructured":"Walker A Bannister K George C Mudge D Yehia M Lonergan M KHA-CARI Guideline: peritonitis treatment and prophylaxis Nephrology 2014 69 71 23944845","DOI":"10.1111\/nep.12152"},{"issue":"2","key":"10.1002\/14651858.CD004679.pub3-BIB0131|cit131","first-page":"85","article-title":"Systems and devices used for peritoneal dialysis","volume":"20","author":"Ward","year":"1986","journal-title":"Medical Instrumentation"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/089686089701700411","article-title":"Technique failure in peritoneal dialysis and its impact on patient survival","volume":"17","author":"Woodrow","year":"1997","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD004679.pub3-BIB0133|cit133","doi-asserted-by":"crossref","unstructured":"Woodrow G Davies S Peritoneal dialysis in CKD. 2010 www.renal.org\/guidelines\/modules\/peritoneal-dialysis-in-ckd#sthash.gkEx1Y5v.dpbs","DOI":"10.1093\/med\/9780199204854.003.210702_update_002"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004679","article-title":"Anti-infective (antiseptics and antibiotics) agents for preventing peritonitis in peritoneal dialysis patients","author":"Strippoli","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004679.pub2","article-title":"Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients","author":"Strippoli","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004679.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0272-6386(04)00941-2","article-title":"Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials","volume":"44","author":"Strippoli","year":"2004","journal-title":"American Journal of Kidney Diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004679.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T09:33:03Z","timestamp":1658914383000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004679.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":136,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004679.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}